Cargando…
Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease
No specific or efficient treatment exists for Alport syndrome, an X-linked hereditary disease caused by mutations in collagen type IV, a crucial component of the glomerular basement membrane. Kidney failure is usually a major complication of the disease, and patients require renal replacement therap...
Autores principales: | Trimarchi, H., Canzonieri, R., Muryan, A., Schiel, A., Araoz, A., Paulero, M., Andrews, J., Rengel, T., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Zotta, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749773/ https://www.ncbi.nlm.nih.gov/pubmed/26942026 http://dx.doi.org/10.1155/2016/1492743 |
Ejemplares similares
-
In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
por: Trimarchi, H., et al.
Publicado: (2017) -
Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease
por: Trimarchi, H., et al.
Publicado: (2015) -
Increased urinary CD80 excretion and podocyturia in Fabry disease
por: Trimarchi, H., et al.
Publicado: (2016) -
In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia
por: Trimarchi, Hernán, et al.
Publicado: (2017) -
Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)